New expansion of foreign direct investments control regime in France and the impact on French biotech companies

Published date01 August 2020
Subject MatterForeign Investment,Biotechnology,Medical Research,Scientific Research,Foreign Direct Investment,France,Research and Development,Merger Controls,Foreign Acquisitions,Non-EU Investors
AuthorGuillaume Vitrich,Hugues Racovski
Law FirmWhite & Case LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT